Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
Clinical trial NCT05853458 · TERMINATED
Trial details
- NCT number
- NCT05853458
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2026-02-26
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.